Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC
TBPH — Theravance Biopharma, Inc.
EXPENSIVE (MOS -950.6%) · Quality 72/100
Price
17.02
Intrinsic value
1.62
Margin of safety
-950.6%
Implied growth (reverse DCF)
+30.8%
model assumes +0.0%
Value Score
16.5
Quality
72
Psychology
2.6
Discovery
10.7
price/volume attention only
Moat score
28
erosion: none
Value Score: bottom 25% of Russell 3000 · Quality: top 12%
Open the interactive Deep Dive for TBPH →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/TBPH - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
Is TBPH undervalued?
As of 2026-09-19, TBPH trades at 17.02 against a computed intrinsic value of 1.62 (-950.6% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.
What is Theravance Biopharma, Inc.'s Value Score?
Theravance Biopharma, Inc.'s Value Score is 16.5 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.